HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

masitinib

a protein kinase inhibitor and antineoplastic agent
Also Known As:
4-((4-methylpiperazin-1-yl)methyl)-N-(4-methyl-3-((4-(pyridin-3-yl)-1,3-thiazol-2-yl)amino)phenyl)benzamide; AB 1010; AB-1010; AB1010; masatinib
Networked: 46 relevant articles (6 outcomes, 16 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Moussy, Alain: 12 articles (01/2015 - 01/2009)
2. Hermine, Olivier: 12 articles (01/2015 - 01/2009)
3. Hermine, O: 9 articles (06/2015 - 11/2008)
4. Dubreuil, Patrice: 9 articles (01/2015 - 01/2009)
5. Moussy, A: 7 articles (06/2015 - 11/2008)
6. Dubreuil, P: 5 articles (06/2015 - 11/2008)
7. Mansfield, Colin D: 5 articles (07/2012 - 01/2009)
8. Mansfield, C D: 4 articles (06/2015 - 09/2009)
9. Gineste, Paul: 4 articles (07/2012 - 01/2009)
10. Rusiecka, Izabela: 2 articles (11/2015 - 01/2015)

Related Diseases

1. Neoplasms (Cancer)
2. Mastocytosis (Mast-Cell Disease)
3. Edema
4. Mast-Cell Leukemia (Leukemia, Mast Cell)
5. Inflammation

Related Drugs and Biologics

1. Protein-Tyrosine Kinases (Tyrosine Kinase)
2. gemcitabine
3. masitinib
4. Doxorubicin (Adriamycin)
5. imatinib (Gleevec)
6. Mesylates (Mesylate)
7. Vinblastine (Vinblastine Sulfate)
8. Memantine (Namenda)
9. Cholinesterases (Cholinesterase)
10. SU 11654

Related Therapies and Procedures

1. Positive-Pressure Respiration (PEEP)
2. Aftercare (After-Treatment)
3. Bone Marrow Transplantation (Transplantation, Bone Marrow)
4. Activities of Daily Living (ADL)